Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable
- Author
- CURSIEFEN, Claus1 ; COLIN, Joseph2 ; SEITZ, Berthold12 ; UDAONDO, Patricia4 6 ; MELLER, Daniel13 ; DUA, Harminder7 ; DANA, Reza3 ; DIAZ-LLOPIS, Manuel4 5 6 ; FARAJ, Lana A7 ; GARCIA-DELPECH, Salvador4 5 6 ; GEERLING, Gerd8 ; PRICE, Francis W9 ; REMEIJER, Lies10 ; ROUSE, Barry T11
[1] Department of Ophthalmology, University of Cologne, Erlangen, Germany
[2] Centre Hospitalier Universitaire Pellegrin, Bordeaux, France
[3] Massachusetts Eye & Ear Infirmary, Schepens Eye Research Institute, Harvard Medical School, Boston, United States
[4] Department of Ophthalmology, La Fe University Hospital, Valencia, Spain
[5] University of Valencia, Valencia, Spain
[6] Biomedical Network Research Centre on Rare Diseases (CIBERER), Valencia, Spain
[7] Division of Ophthalmology and Visual Sciences, University of Nottingham, Nottingham, United Kingdom
[8] Department of Ophthalmology, University of Würzburg, Würzburg, Germany
[9] Price Vision Group and the Cornea Research Foundation of America, Indianapolis, Indiana, United States
[10] Cornea and External Disease Service, The Rotterdam Eye Hospital, Rotterdam, Netherlands
[11] Department of Pathobiology, College of Veterinary Medicine, University of Tennessee, Knoxville, Tennessee, United States
[12] Department of Ophthalmology, University of Saarland, Homburg, Germany
[13] Department of Ophthalmology, University of Essen, Essen, Germany - Source
British journal of ophthalmology. 2012, Vol 96, Num 1, pp 3-9, 7 p ; ref : 84 ref
- CODEN
- BJOPAL
- ISSN
- 0007-1161
- Scientific domain
- Ophthalmology
- Publisher
- BMJ Publishing Group, London
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antiangiogénique Association Conduite à tenir Evolution Indication Kératopathie Néovascularisation Ophtalmologie Pronostic Traitement Pathologie de l'oeil Pathologie du segment antérieur
- Keyword (en)
- Antiangiogenic agent Association Clinical management Evolution Indication Keratopathy Neovascularization Ophthalmology Prognosis Treatment Eye disease Anterior segment disease
- Keyword (es)
- Antiangiogenico Asociación Actitud médica Evolución Indicación Queratopatía Neovascularización Oftalmología Pronóstico Tratamiento Ojo patología Segmento anterior patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B09 Ophthalmology / 002B09E Diseases of cornea, anterior segment and sclera
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B09 Ophthalmology / 002B09N Miscellaneous
- Discipline
- Ophthalmology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 25353628
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1136/bjo.2011.204701 
https://dx.doi.org/10.1136/bjo.2011.204701
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1136\/bjo.2011.204701\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:168:\"Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable\";s:9:\"\u0000*\u0000jtitle\";s:32:\"British journal of ophthalmology\";s:9:\"\u0000*\u0000stitle\";s:17:\"Br. j. ophthalmol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"96\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:1:\"3\";s:8:\"\u0000*\u0000epage\";s:1:\"9\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-1161\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"CURSIEFEN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Claus\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:13:\"COLIN, Joseph\";i:1;s:15:\"SEITZ, Berthold\";i:2;s:17:\"UDAONDO, Patricia\";i:3;s:14:\"MELLER, Daniel\";i:4;s:14:\"DUA, Harminder\";i:5;s:10:\"DANA, Reza\";i:6;s:19:\"DIAZ-LLOPIS, Manuel\";i:7;s:13:\"FARAJ, Lana A\";i:8;s:24:\"GARCIA-DELPECH, Salvador\";i:9;s:14:\"GEERLING, Gerd\";i:10;s:16:\"PRICE, Francis W\";i:11;s:14:\"REMEIJER, Lies\";i:12;s:14:\"ROUSE, Barry T\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJOPAL\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:168:\"Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:20:\"BMJ Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1136\/bjo.2011.204701\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:168:\"Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable\";s:9:\"\u0000*\u0000jtitle\";s:32:\"British journal of ophthalmology\";s:9:\"\u0000*\u0000stitle\";s:17:\"Br. j. ophthalmol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"96\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:1:\"3\";s:8:\"\u0000*\u0000epage\";s:1:\"9\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-1161\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"CURSIEFEN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Claus\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:13:\"COLIN, Joseph\";i:1;s:15:\"SEITZ, Berthold\";i:2;s:17:\"UDAONDO, Patricia\";i:3;s:14:\"MELLER, Daniel\";i:4;s:14:\"DUA, Harminder\";i:5;s:10:\"DANA, Reza\";i:6;s:19:\"DIAZ-LLOPIS, Manuel\";i:7;s:13:\"FARAJ, Lana A\";i:8;s:24:\"GARCIA-DELPECH, Salvador\";i:9;s:14:\"GEERLING, Gerd\";i:10;s:16:\"PRICE, Francis W\";i:11;s:14:\"REMEIJER, Lies\";i:12;s:14:\"ROUSE, Barry T\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJOPAL\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:168:\"Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:20:\"BMJ Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:23:\"10.1136\/bjo.2011.204701\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1136\/bjo.2011.204701\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:168:\"Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable\";s:9:\"\u0000*\u0000jtitle\";s:32:\"British journal of ophthalmology\";s:9:\"\u0000*\u0000stitle\";s:17:\"Br. j. ophthalmol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"96\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:1:\"3\";s:8:\"\u0000*\u0000epage\";s:1:\"9\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-1161\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"CURSIEFEN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Claus\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:13:\"COLIN, Joseph\";i:1;s:15:\"SEITZ, Berthold\";i:2;s:17:\"UDAONDO, Patricia\";i:3;s:14:\"MELLER, Daniel\";i:4;s:14:\"DUA, Harminder\";i:5;s:10:\"DANA, Reza\";i:6;s:19:\"DIAZ-LLOPIS, Manuel\";i:7;s:13:\"FARAJ, Lana A\";i:8;s:24:\"GARCIA-DELPECH, Salvador\";i:9;s:14:\"GEERLING, Gerd\";i:10;s:16:\"PRICE, Francis W\";i:11;s:14:\"REMEIJER, Lies\";i:12;s:14:\"ROUSE, Barry T\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJOPAL\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:168:\"Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:20:\"BMJ Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1136\/bjo.2011.204701\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:168:\"Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable\";s:9:\"\u0000*\u0000jtitle\";s:32:\"British journal of ophthalmology\";s:9:\"\u0000*\u0000stitle\";s:17:\"Br. j. ophthalmol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"96\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:1:\"3\";s:8:\"\u0000*\u0000epage\";s:1:\"9\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-1161\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"CURSIEFEN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Claus\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:13:\"COLIN, Joseph\";i:1;s:15:\"SEITZ, Berthold\";i:2;s:17:\"UDAONDO, Patricia\";i:3;s:14:\"MELLER, Daniel\";i:4;s:14:\"DUA, Harminder\";i:5;s:10:\"DANA, Reza\";i:6;s:19:\"DIAZ-LLOPIS, Manuel\";i:7;s:13:\"FARAJ, Lana A\";i:8;s:24:\"GARCIA-DELPECH, Salvador\";i:9;s:14:\"GEERLING, Gerd\";i:10;s:16:\"PRICE, Francis W\";i:11;s:14:\"REMEIJER, Lies\";i:12;s:14:\"ROUSE, Barry T\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJOPAL\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:168:\"Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:20:\"BMJ Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:23:\"10.1136\/bjo.2011.204701\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:168:\"Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable\";s:9:\"\u0000*\u0000jtitle\";s:32:\"British journal of ophthalmology\";s:9:\"\u0000*\u0000stitle\";s:17:\"Br. j. ophthalmol\";s:7:\"\u0000*\u0000date\";s:4:\"2012\";s:9:\"\u0000*\u0000volume\";s:2:\"96\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:1:\"3\";s:8:\"\u0000*\u0000epage\";s:1:\"9\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0007-1161\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:9:\"CURSIEFEN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Claus\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:13:{i:0;s:13:\"COLIN, Joseph\";i:1;s:15:\"SEITZ, Berthold\";i:2;s:17:\"UDAONDO, Patricia\";i:3;s:14:\"MELLER, Daniel\";i:4;s:14:\"DUA, Harminder\";i:5;s:10:\"DANA, Reza\";i:6;s:19:\"DIAZ-LLOPIS, Manuel\";i:7;s:13:\"FARAJ, Lana A\";i:8;s:24:\"GARCIA-DELPECH, Salvador\";i:9;s:14:\"GEERLING, Gerd\";i:10;s:16:\"PRICE, Francis W\";i:11;s:14:\"REMEIJER, Lies\";i:12;s:14:\"ROUSE, Barry T\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BJOPAL\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:168:\"Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:20:\"BMJ Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"7\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
